Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Cerenome profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cerenome's profit margin for the twelve months ending Jun 30, 2026 was -620.7%. For fiscal 2025 it was -429.4%, against -222.8% the year before. The highest annual figure on record is -222.8% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -429.4% | −206.6 |
| FY2024 | Dec 31, 2024 | -222.8% | +48.2 |
| FY2023 | Dec 31, 2023 | -271.0% | +73.1 |
| FY2018 | Dec 31, 2018 | -344.2% | +499.5 |
| FY2017 | Dec 31, 2017 | -843.7% | −370.2 |
| FY2016 | Dec 31, 2016 | -473.5% | −86.1 |
| FY2015 | Dec 31, 2015 | -387.4% | +367.0 |
| FY2014 | Dec 31, 2014 | -754.5% | −386.9 |
| FY2013 | Dec 31, 2013 | -367.6% | +3.1 |
| FY2012 | Dec 31, 2012 | -370.6% | +35.9 |
| FY2011 | Dec 31, 2011 | -406.5% | −73.4 |
| FY2010 | Dec 31, 2010 | -333.1% | +64.6 |
| FY2009 | Dec 31, 2009 | -397.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2191.2% | −2561.8 |
| Q1 FY2026 | Mar 31, 2026 | -675.7% | +967.5 |
| Q4 FY2025 | Dec 31, 2025 | -417.9% | −141.5 |
| Q3 FY2025 | Sep 30, 2025 | -316.6% | −119.2 |
| Q2 FY2025 | Jun 30, 2025 | 370.6% | +600.4 |
| Q1 FY2025 | Mar 31, 2025 | -1643.2% | −1448.7 |
| Q4 FY2024 | Dec 31, 2024 | -276.4% | +171.7 |
| Q3 FY2024 | Sep 30, 2024 | -197.4% | −40.1 |
| Q2 FY2024 | Jun 30, 2024 | -229.9% | +373.3 |
| Q1 FY2024 | Mar 31, 2024 | -194.5% | +453.0 |
| Q1 FY2019 | Mar 31, 2019 | -448.1% | +581.3 |
| Q4 FY2018 | Dec 31, 2018 | -157.2% | +467.0 |
| Q1 FY2018 | Mar 31, 2018 | -603.1% | +673.3 |
| Q4 FY2017 | Dec 31, 2017 | -647.4% | −312.0 |
| Q3 FY2017 | Sep 30, 2017 | -1029.3% | −292.8 |
| Q2 FY2017 | Jun 30, 2017 | -624.3% | −55.4 |
| Q1 FY2017 | Mar 31, 2017 | -1276.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -335.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -736.5% | – |
| Q2 FY2016 | Jun 30, 2016 | -568.8% | – |
See a number that looks wrong?